IN2014MU00859A - - Google Patents

Info

Publication number
IN2014MU00859A
IN2014MU00859A IN859MU2014A IN2014MU00859A IN 2014MU00859 A IN2014MU00859 A IN 2014MU00859A IN 859MU2014 A IN859MU2014 A IN 859MU2014A IN 2014MU00859 A IN2014MU00859 A IN 2014MU00859A
Authority
IN
India
Prior art keywords
acceptable derivative
pharmaceutical
sulbactam
stereoisomer
compound
Prior art date
Application number
Other languages
English (en)
Inventor
Sachin Bhagwat
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2015/050267 priority Critical patent/WO2015136387A1/en
Priority to EP15706530.1A priority patent/EP3116545A1/en
Priority to IN859MU2014 priority patent/IN2014MU00859A/en
Priority to JP2016555984A priority patent/JP2017507162A/ja
Priority to US15/125,562 priority patent/US20170000775A1/en
Priority to KR1020167025810A priority patent/KR20160126004A/ko
Priority to CN201580014021.1A priority patent/CN106794250A/zh
Publication of IN2014MU00859A publication Critical patent/IN2014MU00859A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN859MU2014 2014-03-14 2015-01-14 IN2014MU00859A (enrdf_load_stackoverflow)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PCT/IB2015/050267 WO2015136387A1 (en) 2014-03-14 2015-01-14 Pharmaceutical compositions comprising antibacterial agents
EP15706530.1A EP3116545A1 (en) 2014-03-14 2015-01-14 Pharmaceutical compositions comprising antibacterial agents
IN859MU2014 IN2014MU00859A (enrdf_load_stackoverflow) 2014-03-14 2015-01-14
JP2016555984A JP2017507162A (ja) 2014-03-14 2015-01-14 抗菌薬を含む医薬組成物
US15/125,562 US20170000775A1 (en) 2014-03-14 2015-01-14 Pharmaceutical compositions comprising antibacterial agents
KR1020167025810A KR20160126004A (ko) 2014-03-14 2015-01-14 항세균제를 포함하는 제약학적 조성물
CN201580014021.1A CN106794250A (zh) 2014-03-14 2015-01-14 包含抗菌剂的药物组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN859MU2014 IN2014MU00859A (enrdf_load_stackoverflow) 2014-03-14 2015-01-14

Publications (1)

Publication Number Publication Date
IN2014MU00859A true IN2014MU00859A (enrdf_load_stackoverflow) 2015-10-02

Family

ID=52589710

Family Applications (1)

Application Number Title Priority Date Filing Date
IN859MU2014 IN2014MU00859A (enrdf_load_stackoverflow) 2014-03-14 2015-01-14

Country Status (7)

Country Link
US (1) US20170000775A1 (enrdf_load_stackoverflow)
EP (1) EP3116545A1 (enrdf_load_stackoverflow)
JP (1) JP2017507162A (enrdf_load_stackoverflow)
KR (1) KR20160126004A (enrdf_load_stackoverflow)
CN (1) CN106794250A (enrdf_load_stackoverflow)
IN (1) IN2014MU00859A (enrdf_load_stackoverflow)
WO (1) WO2015136387A1 (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016151543A1 (en) * 2015-03-25 2016-09-29 Wockhardt Limited Pharmaceutical compositions comprising antibacterial agents
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
BR112021002311A2 (pt) 2018-08-09 2021-05-04 Antabio Sas composto, composição farmacêutica e combinação

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ616806A (en) * 2011-07-26 2015-03-27 Wockhardt Ltd Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
US9095594B2 (en) * 2011-07-26 2015-08-04 Wockhardt Ltd. Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
ES2640520T3 (es) * 2011-09-13 2017-11-03 Wockhardt Limited Compuestos que contienen nitrógeno y su uso

Also Published As

Publication number Publication date
US20170000775A1 (en) 2017-01-05
JP2017507162A (ja) 2017-03-16
CN106794250A (zh) 2017-05-31
WO2015136387A1 (en) 2015-09-17
EP3116545A1 (en) 2017-01-18
KR20160126004A (ko) 2016-11-01

Similar Documents

Publication Publication Date Title
PH12018500591B1 (en) Heterocyclic compounds and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
GEP20207075B (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
MA39749A (fr) Dérivés de pipéridine-dione
PH12020551586A1 (en) Oxysterols and methods of use thereof
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MY181641A (en) Amino pyran ring derivative and composition and use thereof
PH12016501252A1 (en) Novel tetrahydropyridopyrimidine compound or salt thereof
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
NZ783808A (en) Crystalline forms of c21h22cl2n4o2
EP3213746A4 (en) Pharmaceutical composition for oral administration comprising taxane
IN2014CH00840A (enrdf_load_stackoverflow)
EP3720844A4 (en) MEDICINAL COMPOSITIONS
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
IN2014MU00859A (enrdf_load_stackoverflow)
MA39877A (fr) Formes solides d'un composé pharmaceutiquement actif
IN2013MU03308A (enrdf_load_stackoverflow)
TW201613898A (en) Benzofuran analogue as NS4B inhibitor
IN2013MU03704A (enrdf_load_stackoverflow)
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2013MU03422A (enrdf_load_stackoverflow)
IN2013MU03421A (enrdf_load_stackoverflow)
IN2013MU03309A (enrdf_load_stackoverflow)
IN2014MU01194A (enrdf_load_stackoverflow)